• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊癌淋巴结分期及淋巴结受累危险因素的评估

Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer.

作者信息

Balakrishnan Anita, Barmpounakis Petros, Demiris Nikolaos, Andersson Bodil, Brañes Alejandro, de Aretxabala Xavier, Eilard Malin Sternby, Gibbs Paul, Harper Simon J F, Huguet Emmanuel L, Jah Asif, Kosmoliaptsis Vasilis, Lendoire Javier, Liau Siong S, Maithel Shishir, Martin Jack L, Noel Colin, Praseedom Raaj K, Serrablo Alejandro, Adsay Volkan

机构信息

Department of Hepatopancreatobiliary Surgery, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.

Department of Surgery, University of Cambridge, Cambridge, UK.

出版信息

BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf056.

DOI:10.1093/bjsopen/zraf056
PMID:40407730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12100740/
Abstract

BACKGROUND

Nodal assessment in gallbladder cancer remains challenging, particularly in incidental gallbladder cancer. This understages the number of patients with node-positive disease, resulting in prognostic inaccuracy and insufficient adjuvant treatment. This study aimed to identify risk factors for positive nodes in gallbladder cancer and to compare prognostic discrimination of available nodal staging parameters.

METHODS

This international cohort study assessed gallbladder cancer resections undertaken between 1 January 2010 and 31 December 2020. Logistic regression was used to identify risk factors for node-positive status and develop a risk prediction score for positive nodes. Nodal staging models, including nodal site, number of positive nodes, and positive node ratio were compared for greatest prognostic discrimination in gallbladder cancer.

RESULTS

A total of 3676 patients underwent gallbladder cancer resection across 133 centres in 41 countries. Tumour (T) stage (T2, P = 0.012; T3, P = 0.002; and T4, P < 0.001), lymphovascular and perineural infiltration (P < 0.001), and tumour differentiation (P < 0.001) carried the greatest risk of positive nodes. These three parameters comprised the OMEGA Node Positivity Prediction Score (OMEGA-NOPPS) with C-statistics of 0.81 (95% confidence interval 0.78 to 0.84) in the training data set and 0.79 (0.73 to 0.85) in the test data set for identification of node-positive status, highlighting a ≥ 20% increased risk of positive nodes in poorly differentiated tumours with lymphovascular and perineural infiltration despite T1 disease.

CONCLUSION

Data from this large multicentre study confirmed that the number of positive nodes is the most discriminative prognostic model for nodal staging in gallbladder cancer. OMEGA-NOPPS provides three simple parameters to stratify nodal involvement according to risk. Incidental gallbladder cancer with lymphovascular and perineural infiltration and poorly differentiated tumours, including early T stages, should be considered for further treatment.

摘要

背景

胆囊癌的淋巴结评估仍然具有挑战性,尤其是在意外胆囊癌中。这低估了淋巴结阳性疾病患者的数量,导致预后不准确和辅助治疗不足。本研究旨在确定胆囊癌淋巴结阳性的危险因素,并比较现有淋巴结分期参数的预后判别能力。

方法

这项国际队列研究评估了2010年1月1日至2020年12月31日期间进行的胆囊癌切除术。采用逻辑回归来确定淋巴结阳性状态的危险因素,并开发淋巴结阳性的风险预测评分。比较了包括淋巴结部位、阳性淋巴结数量和阳性淋巴结比率在内的淋巴结分期模型,以确定胆囊癌中最大的预后判别能力。

结果

共有3676例患者在41个国家的133个中心接受了胆囊癌切除术。肿瘤(T)分期(T2,P = 0.012;T3,P = 0.002;T4,P < 0.001)、淋巴管和神经周围浸润(P < 0.001)以及肿瘤分化(P < 0.001)是淋巴结阳性的最大风险因素。这三个参数构成了OMEGA淋巴结阳性预测评分(OMEGA-NOPPS),在训练数据集中识别淋巴结阳性状态的C统计量为0.81(95%置信区间0.78至0.84),在测试数据集中为0.79(0.73至0.85),突出显示尽管为T1期疾病,但伴有淋巴管和神经周围浸润的低分化肿瘤中淋巴结阳性风险增加≥20%。

结论

这项大型多中心研究的数据证实,阳性淋巴结数量是胆囊癌淋巴结分期中最具判别力的预后模型。OMEGA-NOPPS提供了三个简单参数,可根据风险对淋巴结受累情况进行分层。对于伴有淋巴管和神经周围浸润以及低分化肿瘤的意外胆囊癌,包括早期T分期,应考虑进一步治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b07f/12100740/33205c4294cc/zraf056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b07f/12100740/a045b440ac76/zraf056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b07f/12100740/33205c4294cc/zraf056f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b07f/12100740/a045b440ac76/zraf056f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b07f/12100740/33205c4294cc/zraf056f2.jpg

相似文献

1
Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer.胆囊癌淋巴结分期及淋巴结受累危险因素的评估
BJS Open. 2025 May 7;9(3). doi: 10.1093/bjsopen/zraf056.
2
Beyond Nodal Stage: A Clinical Study of Colorectal Cancer Outcomes at a Single Tertiary Care Center.超越淋巴结分期:一家三级医疗中心的结直肠癌预后临床研究。
Cureus. 2025 May 18;17(5):e84365. doi: 10.7759/cureus.84365. eCollection 2025 May.
3
Development and validation of a prognostic model for overall survival in pN0 esophageal cancer patients after neoadjuvant chemotherapy: a SEER database-based study.新辅助化疗后pN0期食管癌患者总生存预后模型的建立与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
J Thorac Dis. 2025 May 30;17(5):3326-3344. doi: 10.21037/jtd-2025-910. Epub 2025 May 27.
4
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.新辅助化疗后,针对淋巴结阳性乳腺癌患者的腋窝处理模式发生变化,更多地采用仅前哨淋巴结活检:一项针对土耳其外科医生的调查(MF17 - 01)结果
Langenbecks Arch Surg. 2025 Jun 16;410(1):196. doi: 10.1007/s00423-025-03767-9.
5
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.辅助纳武利尤单抗联合化疗对比安慰剂联合化疗用于 D2 或更广泛淋巴结清扫术后的 III 期胃癌或胃食管结合部癌(ATTRACTION-5):一项随机、多中心、双盲、安慰剂对照的 III 期临床试验。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):705-717. doi: 10.1016/S2468-1253(24)00156-0. Epub 2024 Jun 18.
6
Development of a Prediction Model and Risk Score for Self-Assessment and High-Risk Population Identification in Liver Cancer Screening: Prospective Cohort Study.肝癌筛查中自我评估及高危人群识别的预测模型与风险评分的开发:前瞻性队列研究
JMIR Public Health Surveill. 2024 Dec 30;10:e65286. doi: 10.2196/65286.
7
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non‑small cell lung cancer.对于患有Ia期非小细胞肺癌的八旬及以上老人,肺段切除术并不逊色于肺叶切除术。
Transl Cancer Res. 2025 May 30;14(5):2966-2980. doi: 10.21037/tcr-2024-2575. Epub 2025 May 14.
8
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
9
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma.一种用于原发性皮肤黑色素瘤患者前哨淋巴结阳性的风险预测工具的全球适用性
JAMA Dermatol. 2025 Apr 9. doi: 10.1001/jamadermatol.2025.0318.
10
Survival outcome after systematic lymphadenectomy in non-small cell lung cancer according to the latest proposed edition of the TNM system.根据最新提议的TNM系统版本,非小细胞肺癌系统性淋巴结清扫术后的生存结果。
J Thorac Dis. 2025 May 30;17(5):3128-3137. doi: 10.21037/jtd-2024-2086. Epub 2025 May 27.

本文引用的文献

1
'IHPBA-APHPBA clinical practice guidelines': international Delphi consensus recommendations for gallbladder cancer.'IHPBA-APHPBA 临床实践指南': 胆囊癌国际 Delphi 共识推荐意见。
HPB (Oxford). 2024 Nov;26(11):1311-1326. doi: 10.1016/j.hpb.2024.07.411. Epub 2024 Jul 25.
2
Simple versus radical cholecystectomy and survival for pathologic stage T1B gallbladder cancer.单纯性胆囊切除术与根治性胆囊切除术及病理分期为T1B期胆囊癌的生存率
HPB (Oxford). 2024 Apr;26(4):594-602. doi: 10.1016/j.hpb.2024.01.012. Epub 2024 Jan 24.
3
Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
比较不同的淋巴结分期系统在预测肾细胞癌淋巴结阳性患者总体生存中的作用:一项使用监测、流行病学和最终结果数据库的回顾性队列研究。
BMJ Open. 2023 Apr 26;13(4):e068044. doi: 10.1136/bmjopen-2022-068044.
4
Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study.胆囊癌的手术结果:OMEGA回顾性、多中心、国际队列研究
EClinicalMedicine. 2023 Apr 13;59:101951. doi: 10.1016/j.eclinm.2023.101951. eCollection 2023 May.
5
Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma.肝内胆管癌充分淋巴结清扫的预测因素、模式及影响
Ann Surg Oncol. 2023 Apr;30(4):1966-1977. doi: 10.1245/s10434-022-13044-4. Epub 2023 Jan 9.
6
Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis.T1b 期胆囊癌(GBC)再评估:473 例原位和浸润性 GBC 的临床病理分析,并对文献进行批判性回顾,强调其罕见性和极佳的预后。
Virchows Arch. 2023 Feb;482(2):311-323. doi: 10.1007/s00428-022-03482-6. Epub 2022 Dec 29.
7
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胆道癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10.
8
Gallbladder cancer.胆囊癌。
Nat Rev Dis Primers. 2022 Oct 27;8(1):69. doi: 10.1038/s41572-022-00398-y.
9
Simple cholecystectomy is an adequate treatment for grade I T1bN0M0 gallbladder carcinoma: Evidence from 528 patients.单纯胆囊切除术治疗Ⅰ期 T1bN0M0 胆囊癌是足够的:来自 528 例患者的证据。
World J Gastroenterol. 2022 Aug 21;28(31):4431-4441. doi: 10.3748/wjg.v28.i31.4431.
10
Heterogeneity of management practices surrounding operable gallbladder cancer - results of the OMEGA-S international HPB surgical survey.胆囊癌可切除病例管理实践的异质性 - OMEGA-S 国际肝胆外科调查结果。
HPB (Oxford). 2022 Nov;24(11):2006-2012. doi: 10.1016/j.hpb.2022.06.014. Epub 2022 Jul 9.